Drug Trial Radar · NCT06014762
P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies
Last checked: Nov 20, 2026Latest source record: May 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
120
Planned (sponsor's estimate)
Start
Apr 16, 2024
Primary completion
Mar 2029
Study completion Mar 2041
Sponsor
- Lead sponsor
- Poseida Therapeutics, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Roche-Genentech
- First posted
- Aug 28, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Phase 1 study comprised of open-label, dose escalation and expansion cohort study of P-CD19CD20-ALLO1 allogeneic T stem cell memory (Tscm) CAR-T cells in subjects with relapsed/refractory B cell malignancies
Conditions
- Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
- High-grade B-cell Lymphoma
- Primary Mediastinal Large B-cell Lymphoma (PMBCL)
- Transformed Follicular Lymphoma (tFL)
- Follicular Lymphoma Grade 3B
- DLBCL
- DLBCL - Diffuse Large B Cell Lymphoma
- DLBCL Arising From Follicular Lymphoma
- DLBCL, Diffused Large B Cell Lymphoma
- DLBCL NOS
Interventions
P-CD19CD20-ALLO1Biological
Single weight-based IV administration
RimiducidDrug
Single weight-based IV administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assess the safety and MTD or RDE of P-CD19CD20-ALLO1 based on dose limiting toxicities (DLT)Time frame: Baseline through 28 days
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Loma Linda University Cancer Center
Loma Linda, California
Cedars-Sinai Medical Center
Los Angeles, California
Advent Health Orlando
Orlando, Florida
Indiana University
Indianapolis, Indiana
Our Lady of the Lake Hospital
Baton Rouge, Louisiana
Ochsner Clinic Foundation
New Orleans, Louisiana
Wayne State - Karmanos Cancer Institute
Detroit, Michigan
NYU Grossman School of Medicine
New York, New York
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina
University of Cincinnati
Cincinnati, Ohio
University of Oklahoma, Health Sciences Center
Oklahoma City, Oklahoma
Oregon Health & Science University
Portland, Oregon
Pennsylvania State University
Hershey, Pennsylvania
Prisma Health - Upstate Cancer Institute
Greenville, South Carolina
Vanderbilt University Medical Center
Nashville, Tennessee
Baylor Scott & White Research Institute
Dallas, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.